MedWatch

Ambu plans transformation, targets 5–8% growth in 2022/2023

Ambu has released its full-year report for 2021/2022, including its plans for a ”transition” year – meaning there is an element of uncertainty to the 2022/23 guidance, the report says.

Photo: Ambu/PR

Medtech firm Ambu has just released its full-year report for the fiscal year of 2021/2022, just managing to live up to its financial guidance after several downgrades.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs